Concentrations of protease inhibitors in cord blood after in utero exposure

Abstract

Low protease inhibitor concentrations in the fetus decrease the likelihood of teratogenic and toxic effects of these drugs but could fail to provide protection from transplacental or intrapartum transmission of HIV-1.